Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  Akt/ERK inhibitor ONC201
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
ONC201 in Treating Patients with Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2014-0731, NCI-2015-00504, NCT02392572
Start Over